戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 165作成日:2026年10月23日

Morpholine → 5-Morpholinopyridin-3-amine

https://huagongshe.com/ja/reaction/165

反応式

関与物質

役割名称HCID仕込み量
反応物MorpholineHCID 8083—
反応物tert-Butyl (5-iodopyridin-3-yl)carbamateHCID 45790100—
試薬Cesium carbonateHCID 10796—
触媒1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine)HCID 636044—
触媒Palladium (II) acetateHCID 4144353—
溶媒1,4-DioxaneHCID 31275—
生成物5-Morpholinopyridin-3-amineHCID 5834773727.69%

反応条件

温度150 °C

反応手順

morpholine (0.272 mL, 3.12 mmol), (9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphine) (43.4 mg, 0.07 mmol), tert-butyl 5-iodopyridin-3-ylcarbamate (200 mg, 0.62 mmol), diacetoxypalladium (7.01 mg, 0.03 mmol) and cesium carbonate (407 mg, 1.25 mmol) were suspended in 1,4-dioxane (4 mL) and sealed into a microwave tube. The reaction was heated to 150 °C for 30 minutes in the microwave reactor and cooled to RT. The crude product was purified by ion exchange chromatography, using an SCX column. The desired product was eluted from the column using 7M NH3/MeOH and pure fractions were evaporated to dryness to afford the boc protected product. HCl in dioxane (4M, 5mL) was added to the product . The resulting suspension was stirred at room temperature for 3 hours. The product was evaporated to dryness to afford crude product. The crude product was purified by flash silica chromatography, elution gradient 0 to 10% MeOH plus 1% aqueous ammonia in DCM. Pure fractions were evaporated to dryness to afford 5-morpholinopyridin-3-amine (31.0 mg, 27.7 %) as a cream solid.

情報源と証拠

出典データセット750 AstraZeneca ELN dataset
ORD IDord-34303fd6fd5e47248d4e6485a08472e5
出典メモ750 AstraZeneca ELN dataset